However, in the context of multiple lines of scientific evidence summarized above, supporting increased tumor angiogenesis in HER2+ BRC, the observed differences in vascular VEGFR2 expression in various BRC subtypes are suggestive of underlying biology. This evidence concerns the gene KDR and neoplasm.